Suppr超能文献

根治性前列腺切除术后非尖部阳性手术切缘与前列腺癌 pT2 复发风险最高相关。

Non-apical positive surgical margins after radical prostatectomy for pT2 prostate cancer is associated with the highest risk of recurrence.

机构信息

Copenhagen Prostate Cancer Center, Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

出版信息

J Surg Oncol. 2014 Jun;109(8):818-22. doi: 10.1002/jso.23573. Epub 2014 Feb 13.

Abstract

BACKGROUND AND OBJECTIVE

To investigate how location of positive surgical margins (PSM) in pT2 tumors affect the risk of biochemical recurrence (BR).

METHODS

The study includes 1,133 consecutive patients from 1995 until end of 2011, who had organ-confined disease (pT2) following RP. The location of PSM was stratified into apical and non-apical. BR was defined as the first PSA ≥ 0.2 ng/ml after RP. Risk of BR was analyzed with Kaplan-Meier and Cox regression analysis.

RESULTS

Median follow-up was 3.6 years (range: 0.5-15.5 years). The overall pT2 PSM rate was 26.3%. Overall, a pT2 with PSM had a 3.1-fold increased risk of BR compared to margin negative patients. Patients with pT2 apical and non-apical PSM had a 5-year biochemical recurrence-free survival of 84.9% (95% CI: 77.6-92.2%) and 78.6% (95% CI: 71.3-85.9%), respectively. In multivariate analysis, pT2 apical and non-apical PSM was individually associated with a 2.2- and 3.8-fold increased risk of BR compared to margin negative patients.

CONCLUSION

In our cohort the location of pT2 PSM was associated with time to BR, that is, patients with non-apical pT2 PSM endured the highest risk of BR compared to apical PSM. This may indicate that not all patients with pT2 PSM should be offered adjuvant therapy.

摘要

背景与目的

研究 pT2 肿瘤中的阳性切缘(PSM)位置如何影响生化复发(BR)的风险。

方法

本研究纳入了 1995 年至 2011 年底期间的 1133 例连续患者,这些患者在接受 RP 后患有局限性疾病(pT2)。PSM 的位置分为 apical 和 non-apical。BR 定义为 RP 后首次 PSA≥0.2ng/ml。采用 Kaplan-Meier 和 Cox 回归分析评估 BR 的风险。

结果

中位随访时间为 3.6 年(范围:0.5-15.5 年)。总体 pT2 PSM 率为 26.3%。总体而言,与边缘阴性患者相比,有 PSM 的 pT2 患者发生 BR 的风险增加了 3.1 倍。pT2 apical 和 non-apical PSM 的患者 5 年生化无复发生存率分别为 84.9%(95%CI:77.6-92.2%)和 78.6%(95%CI:71.3-85.9%)。多变量分析显示,与边缘阴性患者相比,pT2 apical 和 non-apical PSM 分别与 BR 风险增加 2.2 倍和 3.8 倍相关。

结论

在我们的队列中,pT2 PSM 的位置与 BR 时间相关,即与 apical PSM 相比,non-apical pT2 PSM 的患者发生 BR 的风险最高。这可能表明并非所有 pT2 PSM 的患者都应接受辅助治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验